NDC11 50111045602
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 50111-0456-02 | 50111-0456 |
| 50111-0456-2 | 50111-0456 |
| 50111-456-02 | 50111-456 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Teva Pharmaceuticals USA, Inc. | cb7aba8d-6913-4f57-8eb4-c6d6ff0b2a29 | 2024-09-02 | Warnings, Adverse reactions | 50111-456-02 50111-456 50111045602 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.